Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on July 30, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

IR System Add-ons (Microplastics)

Closed
NOI-FDA-134639Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 334516
New
Federal
Temp Controlled 42 Plate Hotel
Solicitation # AB482902
Brookhaven Science Associates (BSA) is soliciting quotations for the procurement of a temperature-controlled plate storage incubator with two stackers and a built-in barcode reader, along with comprehensive on-site installation and training for integration with the Art Robbins CryCam UV imaging system at the Brookhaven National Laboratory (BNL) in Upton, New York. The system must support SBS/ANSI-SLAS, low-profile SBS, and Linbro plates, and maintain temperatures between 4C and 25C. This is a small business set-aside solicitation under NAICS code 334516, with a response deadline of October 2, 2026. BSA intends to award a firm fixed-price purchase order to the responsive offeror providing the lowest total evaluated price that meets all technical requirements. Quotations must include pricing, country of origin, Unique Entity Identifier (UEI), and any available price lists, with pricing remaining valid for at least 60 days. Shipping requirements are strict: items under 150lbs may ship via BSA's FedEx account, while others require all-inclusive pricing or DAP terms with BNL as the Importer of Record. The contract incorporates BSA's General and Supplemental Terms and Conditions for non-commercial products and on-site work, including strict site access security protocols, ISO 9001 quality standards, and compliance with FAR clauses such as the Buy American Act. All electrical equipment must be certified by a Nationally Recognized Testing Laboratory, and the supplier must provide a minimum one-year warranty and full system documentation.
Brookhaven National Labor -Doe Contractor

POSTED

about 13 hours ago

DEADLINE

in 21 days

AI Contract Overview

Show more

The U.S. Food and Drug Administration is procuring a counter-propagating mode upgrade for its existing Photothermal mIRageLS microscope under a sole-source, non-competitive acquisition, justified by the exclusive ownership of Optical Photothermal Infrared (O-PTIR) technology by Photothermal Spectroscopy Corp. (PSC), the only entity capable of delivering full system compatibility with the FDA’s current instrumentation. This upgrade, intended for the detection of microplastics and nanoplastics in human foods, requires seamless integration into the existing software platform and must enable electronic switching between co- and counter-propagating imaging modes with sub-500 nm spatial resolution, a capability uniquely provided by PSC through its patented technologies. The acquisition is constrained to PSC due to its exclusive patent portfolio, manufacturer-specific authorization requirements for installation and qualification, and the impossibility of achieving technical functionality with any other vendor. As a registered small business with CAGE code 83PQ8 and NAICS code 334516, PSC is the sole responsible source, and the procurement is structured as a Firm-Fixed-Price purchase order under simplified acquisition procedures, valued between $25,001 and $250,000. Performance is to occur at the FDA’s facility in College Park, Maryland, with acceptance criteria centered on functional integration, software compatibility, and manufacturer-authorized commissioning. No competition is permitted or practicable, and all responders must demonstrate formal authorization from PSC to distribute and service the O-PTIR system, alongside proof of small business status and prior contract performance. The presolicitation was issued on July 30, 2026, with a deadline for capability statements on August 13, 2026, and an anticipated award date no later than September 9, 2026. Communication and submissions are handled exclusively via email to designated FDA contracting personnel, with no formal contract clauses, detailed pricing, or logistical specifications provided at this stage.

General Info

FDA sole-source contract to Photothermal Spectroscopy Corp. for O-PTIR microplastics add-on, compatible with existing system, due to exclusive patents.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

334516 - Analytical Laboratory Instrument ManufacturingView NAICS

Place of Performance

College Park, MD, 20740, USA

Set-Aside

NONE

Documents

(1)

PreSolicitation Notice FDA-134639 IR System Add-ons (Microplastics)

PDFpresolicitation

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Presolicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
Contacts2 people available
OfficeRockville, MD, 20852, USA
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressRockville, MD, 20852, USA
Contacts
Aarati Singal
Sarah Hussain

Full Description

Show more

Pursuant to RFO 5.101(c)(4)(vii), the following identifies the intended source and explains why competition is not practicable for this requirement. 


Intended Contractor: 


Photothermal Spectroscopy Corp. 


325 Chapala St Santa Barbara, CA 93101 


CAGE Code: 83PQ8 



The basis for limiting this solicitation to a single source is that only one source is reasonably available, consistent with RFO 13.101(b) and the single-source standard at RFO 12.201-1(c).


Photothermal Spectroscopy Corp “PSC” is the one and only supplier that can meet the performance requirements outlined in the Statement of Work. The counter-propagating mode upgrade must be 100% compatible with the existing Photothermal mIRageLS to provide a seamless integration and establish full system communication and control through the single, existing software currently at FDA. PSC owns the patent for intellectual property protecting the O-PTIR technology and its associated capabilities. O-PTIR is protected by multiple patents and is exclusively available from Photothermal Spectroscopy. PSC will be the only provider to support the FDA in this requirement of the necessary parts and knowledgeable installation team to ensure 100% compatibility of the upgrade with the current FDA instrument. Photothermal is a US company and is a registered small business. A Brand Name acquisition is recommended, since only one provider meets the requirements for the acquisition.  


A written single-source justification has been prepared and approved in accordance with RFO 12.201-1(c) and RFO 13.101(b).

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human induced pluripotent stem cell (iPSC)-derived hindbrain organoid functional assay services. The project aims to support in vitro research evaluating drug-induced effects on respiratory-relevant neural circuits over an eighteen-month period of performance. The scope of work is divided into two primary components: the provision of human hindbrain organoids and associated culture materials through twelve scheduled deliveries to the FDA White Oak Campus, and the performance of functional characterization services at the contractor's laboratory. Functional characterization will utilize three-dimensional multi-electrode array (3D MEA) technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Deliverables include the delivery of 96 organoids in the first shipment followed by 48 organoids in subsequent deliveries, as well as raw data, analyzed data, analysis files, and comprehensive study reports. This acquisition is conducted as a commercial service under FAR Part 12, with the government restricting competition based on market research identifying OrganoTherapeutics SARL as the only source capable of meeting the complete requirement for both the specific organoid products and the associated functional assay services.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 13 hours ago

DEADLINE

in 6 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS